TrialRenal failure2017

Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study.

Adrian Vlad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.